Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,614 across all filing types
Latest filing 2025-08-29 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
2025年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "深圳市海王生物工程股份有限公司2025 年半年度财务报告" which translates to "Shenzhen Haiwang Bioengineering Co., Ltd. 2025 Semi-Annual Financial Report." It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period of 2025. The length of the document is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content includes actual financial data and analysis for a period shorter than a full fiscal year, consistent with an interim or quarterly report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-29 Chinese
监事会关于第九届监事会第二十一次会议相关事项的意见
Regulatory Filings Classification · 95% confidence The document is a short statement from the Supervisory Board of Shenzhen Haiwang Bioengineering Co., Ltd. regarding their opinion on a guarantee continuation related to an external guarantee. It is a formal opinion or approval from the supervisory board on a specific corporate matter, not a financial report, audit, or regulatory filing. The document length is very short (318 characters), and it does not contain financial data, earnings, or management discussion. It is not an announcement of voting results or a meeting presentation. It is best classified as a Regulatory Filing (RNS) because it is a formal corporate announcement that does not fit other specific categories.
2025-08-14 Chinese
第九届董事局第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of Shenzhen Haier Bioengineering Co., Ltd. It details the meeting date, attendance, agenda items discussed, voting results, and mentions that certain proposals will be submitted to the shareholders' meeting later. The document does not contain financial statements, audit information, or detailed financial data. It is not a report but an announcement of board decisions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on board resolutions, confirming this classification.
2025-08-14 Chinese
关于暂不召开股东大会的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (575 characters) from Shenzhen Haiwang Bioengineering Co., Ltd. It states that the company will temporarily not hold a shareholders' meeting (AGM) and will notify shareholders later. It references board and supervisory meetings and mentions proposals to be submitted to the shareholders' meeting in the future. There is no financial data, no detailed report, no voting results, and no presentation materials. The document is an announcement about the scheduling of a shareholders' meeting, not the meeting materials or results themselves. Therefore, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about corporate governance matters that does not fit other specific categories.
2025-08-14 Chinese
第九届监事会第二十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 21st meeting of the 9th Supervisory Board of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting's convening, voting results, and references to other announcements for further details. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a regulatory announcement about board-level decisions and meeting outcomes. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. The document length is short and it is not a report publication announcement or certification. Therefore, the classification is RNS with high confidence.
2025-08-14 Chinese
关于对外担保进展暨解除对外担保的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the progress and release of external guarantees. It details board meetings and shareholder meetings approving guarantee-related proposals, the status of guarantees provided to subsidiaries and related companies, and the current guarantee balance. The document is relatively short (763 characters) and focuses on guarantee status updates rather than financial results or detailed reports. It does not contain financial statements or detailed financial analysis. This type of announcement fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about guarantee obligations and their release, not a full financial report or a specific category like capital update or management change.
2025-08-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.